The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gazdanova A.A.

Sechenov First Moscow State Medical University (Sechenov University)

Lenkova N.I.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Ryazantseva O.V.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Astakhova Z.T.

North Ossetian State Medical Academy

Sivkov A.S.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Perkov A.V.

Sechenov First Moscow State Medical University

Knyazeva S.A.

Sechenov First Moscow State Medical University (Sechenov University)

Solovieva S.A.

I.M. Sechenov First Moscow State Medical University (Sechenov University)

Plieva A.S.

North Ossetian State Medical Academy

Skin alterations as possible clinical markers of diabetes mellitus and metabolic syndrome

Authors:

Gazdanova A.A., Lenkova N.I., Ryazantseva O.V., Astakhova Z.T., Sivkov A.S., Perkov A.V., Knyazeva S.A., Solovieva S.A., Plieva A.S.

More about the authors

Journal: Russian Journal of Preventive Medicine. 2024;27(7): 101‑107

Read: 1265 times


To cite this article:

Gazdanova AA, Lenkova NI, Ryazantseva OV, et al. . Skin alterations as possible clinical markers of diabetes mellitus and metabolic syndrome. Russian Journal of Preventive Medicine. 2024;27(7):101‑107. (In Russ.)
https://doi.org/10.17116/profmed202427071101

Recommended articles:
Meta­bolic syndrome and anti­psychotic therapy of schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):165-170
Application of modern methods for acti­vation of brain functions in obese patients (literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):54-61
Diabetic reti­nopathy and pregnancy. Russian Annals of Ophthalmology. 2024;(6):145-151
Rela­tionship between meta­bolic syndrome components and pathology of the red border of the lips and oral mucosa. Russian Journal of Operative Surgery and Clinical Anatomy. 2024;(4-2):58-63
Psoriasis: analysis of como­rbid pathology. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):16-21
Cognitive functions asse­ssment of elde­rly patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):46-50

References:

  1. Sodagar S, Ghane Y, Heidari A, et al. Association between metabolic syndrome and prevalent skin diseases: A systematic review and meta-analysis of case-control studies. Health Science Reports. 2023;6(9):e1576. https://doi.org/10.1002/hsr2.1576
  2. Hu Y, Zhu Y, Lian N, et al. Metabolic Syndrome and Skin Diseases. Frontiers in Endocrinology. 2019;10:788.  https://doi.org/10.3389/fendo.2019.00788
  3. Fatima F, Das A, Kumar P, et al. Skin and Metabolic Syndrome: An Evidence Based Comprehensive Review. Indian Journal of Dermatology. 2021; 66(3):302-307.  https://doi.org/https://doi.org/10.4103/ijd.IJD_728_20
  4. Hirt PA, Castillo DE, Yosipovitch G, et al. Skin changes in the obese patient. Journal of the American Academy of Dermatology. 2019;81(5):1037-1057. https://doi.org/10.1016/j.jaad.2018.12.070
  5. Ozlu E, Uzuncakmak TK, Takır M, et al. Comparison of cutaneous manifestations in diabetic and nondiabetic obese patients: A prospective, controlled study. Northern Clinics of Istanbul. 2018;5(2):114-119.  https://doi.org/10.14744/nci.2017.68553
  6. Engin B, Özkoca D, Kutlubay Z, et al. Metabolic syndrome in dermatology: Treatment and Management for Dermatologists. Dermatologic Therapy. 2019;32(2):e12812. https://doi.org/10.1111/dth.12812
  7. Ali Z, Ulrik CS, Agner T, et al. Association between Atopic Dermatitis and the Metabolic Syndrome: A Systematic Review. Dermatology. 2018;234(3-4): 79-85.  https://doi.org/10.1159/000491593
  8. Menon S, Refaey A, Guffey D, et al. Optimizing maturity-onset diabetes of the young detection in a pediatric diabetes population. Pediatric Diabetes. 2022;23:447-456.  https://doi.org/10.1111/pedi.13329
  9. Radu AM, Carsote M, Dumitrascu MC, et al. Acanthosis Nigricans: Pointer of Endocrine Entities. Diagnostics (Basel). 2022;12(10):2519. https://doi.org/10.3390/diagnostics12102519
  10. Marchand L, Gaimard M, Luyton C. All about skin manifestations of insulin resistance and type 2 diabetes: acanthosis nigricans and acrochordons. Postgraduate Medical Journal. 2020;96(1134):237.  https://doi.org/10.1136/postgradmedj-2019-136834
  11. Mintoff D, Benhadou F, Pace NP, Frew JW. Metabolic syndrome and hidradenitis suppurativa: epidemiological, molecular, and therapeutic aspects. International Journal of Dermatology. 2022;61(10):1175-1186. https://doi.org/10.1111/ijd.15910
  12. Brishkoska-Boshkovski V, Kondova-Topuzovska I, Damevska K, Petrov A. Comorbidities as Risk Factors for Acute and Recurrent Erysipelas. Open Access Macedonian Journal of Medical Sciences. 2019;7(6):937-942.  https://doi.org/10.3889/oamjms.2019.214
  13. Cheong HS, Chang Y, Joo EJ, et al. Metabolic Obesity Phenotypes and Risk of Cellulitis: A Cohort Study. Journal of Clinical Medicine. 2019;8(7):953.  https://doi.org/10.3390/jcm8070953
  14. Akbaş A, Kılınç F, Şener S, et al. Investigation of the relationship between seborrheic dermatitis and metabolic syndrome parameters. Journal of Cosmetic Dermatology. 2022;21(11):6079-6085. https://doi.org/10.1111/jocd.15121
  15. Akin Belli A, Ozbas Gok S, Akbaba G, et al. The relationship between rosacea and insulin resistance and metabolic syndrome. European Journal of Dermatology: EJD. 2016;26(3):260-264.  https://doi.org/10.1684/ejd.2016.2748
  16. Güven M, Anık A, Ünüvar T, et al. Cutaneous manifestations of obesity in Turkish children: A comparative study. Pediatric Dermatology. 2022;39(4):513-519.  https://doi.org/10.1111/pde.14978
  17. Sabah Abdulridha Budair A, Ismail Al Hamdi K, Ali Mansour A. Non-Infectious Dermatological Manifestations among Patients with Diabetes Mellitus in Basrah, Iraq. Archives of Razi Institute. 2022;77(1):467-475.  https://doi.org/10.22092/ARI.2021.356588.1874
  18. Kochet KA, Lytus IA, Svistunov IV, et al. Skin pathology in diabetes mellitus: clinical and pathophysiological correlations (review). Georgian Medical News. 2017;(273):41-46. (In Russ.).
  19. Shtoda UM, Slesarenko NA, Rodionova TI, et al. Dermatological manifestations of diabetes mellitus. Sovremennye problemy nauki i obrazovanija. 2014;2:371. (In Russ.). https://science-education.ru/ru/article/view?id=12839
  20. Svechnikova EV, Lykova SG, Nemchaninova OB, Morzhanaeva MAClinical features of skin lesions in patients with diabetes mellitus. Farmateka. 2020;27(12):20-25. (In Russ.). https://doi.org/10.18565/pharmateca.2020.12.20-25
  21. Naik PP, Farrukh SN. Clinical Significance of Diabetic Dermatopathy. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2020;13: 4823-4827. https://doi.org/10.2147/DMSO.S286887
  22. Gazdanova AA, Knyazeva SA, Ermolaeva AS, et al. Clinical and diagnostic significance of somatic diseases skin manifestations. Russian Journal of Preventive Medicine. 2023;26(11):98-108. (In Russ.). https://doi.org/10.17116/profmed20232611198
  23. Gazdanova AA, Lenkova NI, Ryazantseva OV, et al. Inspection of the skin and its additives: relevance in the diagnostics of endocrine diseases. Terapiya. 2022;8(10-62):106-116. (In Russ.). https://doi.org/10.18565/therapy.2022.10.106-116
  24. Erfurt-Berge C, Heusinger V, Reinboldt-Jockenhöfer F, et al. Comorbidity and Therapeutic Approaches in Patients with Necrobiosis Lipoidica. Dermatology (Basel, Switzerland). 2022;238(1):148-155.  https://doi.org/10.1159/000514687
  25. Ruzieva SkH. Dermatological manifestations of endocrine diseases. Vestnik sovremennyh issledovanij. 2018;6.1(21):85-90. (In Russ.).
  26. Zavorins A, Silova A, Voicehovska J, et al. Rubeosis faciei diabeticorum is not associated with oxidative stress and skin autofluorescence. Anais Brasileiros de Dermatologia. 2019;94(5):561-566.  https://doi.org/10.1016/j.abd.2019.09.016
  27. Pereira M, Pinheiro RR, Lencastre A, et al. Scleredema diabeticorum. Dermatology Reports. 2022;14(4):9477. https://doi.org/10.4081/dr.2022.9477
  28. Svoboda SA, Shields BE. Cutaneous Manifestations of Nutritional Excess: Pathophysiologic Effects of Hyperglycemia and Hyperinsulinemia on the Skin. Cutis. 2021;107(2):74-78.  https://doi.org/10.12788/cutis.0173
  29. Domingos A, Calças R, Carias E, et al. Acquired perforating dermatosis with associated complicated cellulitis and amputation in a hemodialysis patient. Clinical Nephrology. Case Studies. 2021;9:33-38.  https://doi.org/10.5414/CNCS110297
  30. Gazdanova AA, Gorodetskaya GI, Perkov AV, et al. Cutaneous manifestations of endocrine disorders. Klinicheskaya dermatologiya i venerologiya. 2022;21(2):230-237. (In Russ.). https://doi.org/10.17116/klinderma202221021230
  31. Julka S, Jamdagni N, Verma S, et al. Yellow palms and soles: A rare skin manifestation in diabetes mellitus. Indian Journal of Endocrinology and Metabolism. 2013;17(Suppl 1):S299-300.  https://doi.org/10.4103/2230-8210.119625
  32. Guarneri C, Guarneri F, Borgia F, et al. Finger pebbles in a diabetic patient: Huntley’s papules. International Journal of Dermatology. 2005;44(9):755-756.  https://doi.org/10.1111/j.1365-4632.2004.02580.x
  33. Trihan JE, Lanéelle D, Metcalfe N, et al. Diabetes-associated dermatological manifestations in primary care and their association with vascular complications. Journal of Diabetes and Metabolic Disorders. 2020;19(2):989-996.  https://doi.org/10.1007/s40200-020-00594-1
  34. Saydam O, Ozgen Saydam B, Adiyaman SC, et al. Risk factors for diabetic foot ulcers in metreleptin naïve patients with lipodystrophy. Clinical Diabetes and Endocrinology. 2021;7(1):18.  https://doi.org/10.1186/s40842-021-00132-9
  35. Xu XH, Carvalho V, Wang XH, et al. Lipohypertrophy: prevalence, clinical consequence and pathogenesis. Chinese Medical Journal. 2020;134(1):47-49.  https://doi.org/10.1097/CM9.0000000000000970
  36. Duff M, Demidova O, Blackburn S, Shubrook J. Cutaneous Manifestations of Diabetes Mellitus. Clinical Diabetes. 2015;33(1):40-48.  https://doi.org/10.2337/diaclin.33.1.40
  37. Coerdt KM, Zolper EG, Starr AG, et al. Cutaneous mucormycosis of the lower extremity leading amputation in two diabetic patients. Archives of Plastic Surgery. 2021;48(2):231-236.  https://doi.org/10.5999/aps.2020.00549
  38. Wu JJ, Kavanaugh A, Lebwohl MG, et al. Psoriasis and metabolic syndrome: implications for the management and treatment of psoriasis. Journal of the European Academy of Dermatology and Venereology: JEADV. 2022;36(6): 797-806.  https://doi.org/10.1111/jdv.18044
  39. Potekaev NN, Kruglova LS, Fedotova KYu, et al. Lichen planus as a part of syndromes: case studies. Klinicheskaya dermatologiya i venerologiya. 2016;(3): 17-23. (In Russ.). https://doi.org/10.17116/klinderma201615317-23
  40. Daye M, Temiz SA, Işık B, et al. Relationship between acanthosis nigricans, acrochordon and metabolic syndrome in patients with lichen planus. International Journal of Clinical Practice. 2021;75(10):e14687. https://doi.org/10.1111/ijcp.14687
  41. Lee JH, Ju HJ, Seo JM, et al. Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis. The Journal of Investigative Dermatology. 2023;143(5):777-789.e6.  https://doi.org/10.1016/j.jid.2022.10.021
  42. Pierce J, Patel T, Scott C. Eruptive Xanthomas. Mayo Clinic Proceedings. 2021;96(12):3097-3098. https://doi.org/10.1016/j.mayocp.2021.09.019
  43. Anaba LE, Ogunbiyi OA, George OA. Adolescent Facial Acne Vulgaris and Body Mass Index: Any Relationship? West African Journal of Medicine. 2019; 36(2):129-132. 
  44. Sas K, Reich A. High Body Mass Index is a Risk Factor for Acne Severity in Adolescents: A Preliminary Report. Acta Dermatovenerologica Croatica: ADC. 2019;27(2):81-85. 
  45. Gopinath H, Upadya GM. Metabolic syndrome in androgenic alopecia. Indian Journal of Dermatology, Venereology and Leprology. 2016;82(4):404-408.  https://doi.org/10.4103/0378-6323.174421
  46. Vora RV, Kota RKSK, Singhal RR, Anjaneyan G. Clinical Profile of Androgenic Alopecia and Its Association with Cardiovascular Risk Factors. Indian Journal of Dermatology. 2019;64(1):19-22.  https://doi.org/10.4103/ijd.IJD_526_16
  47. Unluhizarci K, Karaca Z, Kelestimur F. Role of insulin and insulin resistance in androgen excess disorders. World Journal of Diabetes. 2021;12(5):616-629.  https://doi.org/10.4239/wjd.v12.i5.616

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.